Thus, defining the impacts of the diabetic milieu, whether T1D-associated pro-inflammatory cytokines or T2D-associated hyperglycemia and lipotoxicity, has the promise to reveal how β-cell transcriptional profiles may be altered upon changes in expression of LDB1:ISL1 complex components and/or complex formation. The gene discussed is ISL1; the disease is Hyperglycemia.